Iovanace Biotherapeutics (IOVA) PT Raised to $32 at H.C. Wainwright; 'TILs Continue to Shine at ASCO'
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $32.00 (from $26.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
